SALM Ex-Dividend Reminder - 6/12/13

Looking at the universe of stocks we cover at Dividend Channel, on 6/12/13, Salem Communications Corp. (SALM) will trade ex-dividend, for its quarterly dividend of $0.05, payable on 6/28/13. As a percentage of SALM's recent stock price of $7.60, this dividend works out to approximately 0.66%, so look for shares of Salem Communications Corp. to trade 0.66% lower — all else being equal — when SALM shares open for trading on 6/12/13.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for SALM, showing historical dividends prior to the most recent $0.05 declared by Salem Communications Corp.:

SALM+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from SALM is likely to continue, and whether the current estimated yield of 2.63% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of SALM shares, versus its 200 day moving average:

Salem Communications Corp. 200 Day Moving Average Chart

Looking at the chart above, SALM's low point in its 52 week range is $4.62 per share, with $10.14 as the 52 week high point — that compares with a last trade of $7.60.

In Monday trading, Salem Communications Corp. shares are currently up about 1.1% on the day.

null

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says